SEI Investments’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-54,466
Closed -$1.81M 2549
2020
Q2
$1.81M Buy
54,466
+8,221
+18% +$262K 0.01% 1314
2020
Q1
$1.26M Buy
46,245
+8,890
+24% +$248K ﹤0.01% 1358
2019
Q4
$737K Sell
37,355
-3,774
-9% -$60.4K ﹤0.01% 1764
2019
Q3
$533K Buy
41,129
+562
+1% +$6.79K ﹤0.01% 1855
2019
Q2
$505K Buy
+40,567
New +$539K ﹤0.01% 1873
2018
Q3
Sell
-69
Closed -$1K 3693
2018
Q2
$1K Sell
69
-35
-34% -$751 ﹤0.01% 3561
2018
Q1
$2K Hold
104
﹤0.01% 3283
2017
Q4
$2K Hold
104
﹤0.01% 3157
2017
Q3
$2K Buy
104
+41
+65% +$685 ﹤0.01% 3027
2017
Q2
$1K Sell
63
-6,576
-99% -$100K ﹤0.01% 3010
2017
Q1
$89K Buy
6,639
+6,600
+16,923% +$103K ﹤0.01% 1977
2016
Q4
$1K Hold
39
﹤0.01% 2858
2016
Q3
$0 Buy
39
+32
+457% +$376 ﹤0.01% 3039
2016
Q2
$0 Hold
7
﹤0.01% 2801
2016
Q1
$0 Hold
7
﹤0.01% 2707
2015
Q4
$0 Sell
7
-26,386
-100% -$442K ﹤0.01% 2764
2015
Q3
$433K Buy
26,393
+26,386
+376,943% +$540K ﹤0.01% 1342
2015
Q2
$0 Hold
7
﹤0.01% 2400
2015
Q1
$0 Hold
7
﹤0.01% 2403
2014
Q4
$0 Buy
+7
New +$80 ﹤0.01% 2279

Other funds holding MNTA

SEI Investments's MNTA Position: Q3 2020 in Review

SEI Investments sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 54,466 shares — an estimated $1.81M sold.

SEI Investments first reported a position in MNTA in Q4 2014 and held it in 20 quarters. The position peaked at $1.81M in Q2 2020. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

  • SEI Investments reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • SEI Investments sold 54,466 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $1.81M.
  • SEI Investments first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2014 and held it in 20 quarters.
  • SEI Investments's Momenta Pharmaceuticals, Inc. position peaked at $1.81M in Q2 2020.
  • 211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on SEI Investments's 13F filing for Q3 2020, filed 6 Nov 2020.